Clinical Trials Logo

Eyelid Diseases clinical trials

View clinical trials related to Eyelid Diseases.

Filter by:

NCT ID: NCT02786550 Recruiting - Clinical trials for Other Degenerative Disorders of Eyelid and Periocular Area

Botulinum Toxin to Improve Lower Blepharoplasty Scar

Start date: June 2016
Phase: Phase 4
Study type: Interventional

The combination of Botulinum toxin for crow feet (lateral part of orbicularis oculi muscle) and lower blaphaloplasty might have reduces the tension on the end of lower blaphaloplasty incision whereas the scar is more visible on patient. The main aim of this trial is to investigate whether the injection of Botulinum toxin into the bilateral orbicularis oculi muscles could improve the appearance of the scar after lower blepharoplasty.

NCT ID: NCT01190397 Completed - Eyelid Diseases Clinical Trials

Warming Efficiency of Warm Compresses Versus BLEPHASTEAM® in Eyelid Therapy

Start date: September 2010
Phase: Phase 1
Study type: Interventional

The eyelid warming device is designed to relieve the symptoms of dysfunction of the glands in the eyelids Phase I, prospective, comparative study, investigator masked , monocentric Objectives are To assess and compare the warming and moisture of Blephasteam® device versus the warming and moisture of warm and moist compresses. To assess and compare safety on the ocular surface after 10 minutes of Blephasteam® application versus after 10 minutes of warm and moist compresses application

NCT ID: NCT01189474 Completed - Eyelid Diseases Clinical Trials

Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases

ESPOIR Ext
Start date: June 2010
Phase: Phase 4
Study type: Interventional

Multicentric study, open label, uncontrolled phase IV in 140 patients with meibomian glands dysfunction . Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized. This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21. Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.

NCT ID: NCT01091311 Completed - Eyelid Diseases Clinical Trials

Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases

ESPOIR
Start date: May 2010
Phase: Phase 4
Study type: Interventional

Multicentric study, open label, uncontrolled phase IV in 30 patients with meibomian glands dysfunction . Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized. This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21. Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.

NCT ID: NCT01086943 Completed - Eyelid Diseases Clinical Trials

Clinical Safety Study on an Eyelid Warming Device to Evaluate the Eyelid and Cornea Temperature in Healthy Volunteers

Start date: n/a
Phase: Phase 1
Study type: Interventional

The eyelid warming device is designed to relieve the symptoms of dysfunction of the glands in the eyelids. Prospective, non comparative, open, monocentre study. The objectives are: - To verify and establish the temperature of the eyelids and cornea for each eye before and after 10 minutes device application - To evaluate the ocular surface, NIBUT and IOP before and after device application - To determine the acceptability of healthy volunteers on the practical use of this device The subjects will attend 2 visits.